Apr 19, 2024
427:415
For every 415 shares held, investors received 427. The price per share adjusted from $0.06 to $0.06.
The split itself did not change the total investment value.
Amplia Therapeutics Ltd. (ASX:ATX) operates in the Biotechnology industry.
Amplia Therapeutics Ltd. company overviewAmplia Therapeutics Ltd.'s most recent stock split was on April 19, 2024. It was a 427-for-415 forward split, so shareholders received 427 shares for every 415 they held.
Amplia Therapeutics Ltd. (ASX:ATX) has split its stock 5 times: a 570-for-563 split on June 15, 2016, a 1-for-10 reverse split on May 9, 2018, a 40-for-37 split on July 3, 2020, a 95-for-94 split on November 15, 2021, and a 427-for-415 split on April 19, 2024.
Amplia Therapeutics Ltd. has split its stock 5 times. This history records 5 splits between June 15, 2016 and April 19, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Amplia Therapeutics Ltd.'s 427-for-415 split on April 19, 2024, every 415 shares became 427 shares.
Amplia Therapeutics Ltd. has not announced a new split in our records. Its most recent split was on April 19, 2024, 2 years ago. Companies announce splits in advance, and any new ASX:ATX split will appear on this page.
Already premium?